临床CT与micro-CT对照评估肺气肿漏诊
本研究纳入89例不同严重程度患者,比较临床CT低衰减区百分比(LAA)与micro-CT平均内衬间隔(MLI)对肺气肿的检出能力。结果显示micro-CT MLI与组织学MLI及临床CT LAA均高度相关;但30%临床CT LAA≤5%的患者在micro-CT上MLI升高,提示临床CT存在早期肺气肿漏诊,尤见于曾吸烟者、pre-COPD及轻度COPD患者。
要点
- 临床CT LAA≤5%不能排除早期肺气肿,需警惕曾吸烟者与轻度COPD患者。
- micro-CT MLI可显示临床CT无法分辨的细微空气腔扩大。
- 报告LAA正常时,对pre-COPD及GOLD I级患者仍应结合临床综合判断。
核心结论
- micro-CT可敏感检出细微肺气肿改变,暴露当前临床CT诊断存在低估早期肺气肿的局限。
研究设计与样本
- 研究纳入89例患者,包括从不吸烟15例、曾吸烟9例、pre-COPD 19例、GOLD I/II级18/12例、GOLD III/IV级3/13例。
- 所有患者均接受肺功能检查、术前临床CT,并对移植肺标本至少4个组织芯进行micro-CT扫描及MLI计算。
- 在29例代表性患者亚组中行组织学验证。
关键影像表现/征象
- 30%临床CT LAA≤5%的患者在micro-CT上表现为MLI升高,即存在临床CT未能发现的肺气肿改变。
- micro-CT MLI升高而临床CT LAA未升高的漏诊病例最多见于曾吸烟者(22%)、pre-COPD(26%)和轻度COPD(23%)。
诊断标准与关键数值
- 组织学MLI与micro-CT MLI相关系数r=0.84,p<0.001。
- 临床CT LAA与患者micro-CT平均MLI相关系数r=0.83,p<0.001。
- 临床CT LAA≤5%被作为无肺气肿的界值,该界值下micro-CT仍有30%患者MLI升高。
临床应用与阅片要点
- 日常阅片时不能仅以LAA阈值判断有无肺气肿,尤其对曾吸烟、pre-COPD和GOLD I级患者应保持高度怀疑。
- 临床CT上LAA正常但肺功能或临床表现提示早期气道病变者,应考虑存在影像分辨率不足所致的假阴性。
局限性
- 研究基于移植肺标本,不能反映所有COPD患者的肺气肿空间分布全貌。
- 组织学验证仅在29例亚组中进行,样本代表性有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: Objective quantification of emphysema on clinical computed tomography (CT) in patients with chronic obstructive pulmonary disease (COPD) relies primarily on the percentage of low attenuation area (LAA). However, this approach is limited by spatial resolution, potentially leading to underestimation of subtle disease. The mean linear intercept (MLI) is a well-established histological marker of airspace enlargement. We developed an automated micro-CT-based approach to quantify the MLI that is less labour-intensive than existing methods. Micro-CT MLI was systematically compared with clinical CT LAA and histological MLI.
MATERIALS AND METHODS: The study included 89 patients with different disease severities, including never-smokers (n = 15), ever-smokers (n = 9), pre-COPD (n = 19), mild COPD (GOLD I/II, n = 18/12), and severe COPD (GOLD III/IV, n = 3/13). All patients underwent spirometry, clinical CT before surgery, and at least 4 tissue cores per explanted lung specimen were scanned with micro-CT and used for the MLI computation. Histological validation was performed in a representative subset of patients (n = 29).
RESULTS: MLI computed on histology was correlated with micro-CT-based MLI (r = 0.84, p < 0.001). A similar correlation (r = 0.83, p < 0.001) was found between the LAA on clinical CT and the average MLI of a patient on micro-CT. However, 30% of patients with non-elevated LAA (≤ 5%) exhibited elevated MLI on micro-CT, indicating underdiagnosed emphysema on clinical CT. The prevalence of undetected cases was the highest among ever-smokers (22%), pre-COPD patients (26%), and patients with mild COPD (23%).
CONCLUSION: Micro-CT enables sensitive quantitative detection of subtle emphysematous changes, revealing important limitations of current clinical CT-based diagnostics.
KEY POINTS: Question Is LAA-based emphysema thresholding on clinical CT able to accurately detect mild emphysema? Findings Emphysematous changes were detected in 30% of patients without emphysema on clinical CT, particularly among ever-smokers, pre-COPD, and mild COPD patients. Clinical relevance Micro-CT exposes early emphysematous changes undetectable on clinical CT, enabling refined COPD phenotyping and advancing diagnostic development.
引用
- Van der Rauwelaert, Lapperre, Snoeckx, et al. Uncovering underdiagnosed emphysema: comparative assessment using clinical CT and micro-CT. Eur Radiol. 2026. PMID: 42645341. doi:10.1007/s00330-026-12831-x
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。